Harrow Health's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Harrow Health (NASDAQ:HROW) is expected to release its quarterly earnings report on Monday, 2023-11-13, with analysts estimating an EPS of $0.05. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Harrow Health's stock price has been sensitive to earnings performance and guidance. Last quarter, the company beat EPS estimates but saw a 15.45% drop in share price the following day. Over the last year, HROW shares have increased by 9.31%, indicating a generally positive sentiment among long-term shareholders.
November 10, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Harrow Health is anticipated to report quarterly earnings with an EPS of $0.05. Investors will focus on earnings results and future guidance, which historically have influenced the stock price significantly.
The short-term impact on HROW's stock price will likely hinge on whether the company meets or exceeds the EPS estimate and provides positive future guidance. However, given the historical stock price drops after previous earnings beats, the market reaction could be unpredictable. The importance is high due to the direct correlation between earnings reports and stock performance, but confidence is not at the maximum because market reactions can be inconsistent.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100